Evidence map›Paper›PMID 35635086›Full record

ArticleBioengineered2022

FAM83A antisense RNA 1 (

Huijie Zhao, Yinghan Wang, Xing Wu, Xaofei Zeng, Baoyue Lin, Shengmin Hu, Shenglin Zhang, Yu Li, Zhiqing Zhou, Yujie Zhou and 4 more

Open access · goldAbstract read
In one paragraph

Article in Bioengineered, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. The role of LncRNA-mediated autophagy in cancer progression.Frontiers in cell and developmental biology · 2024
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Huijie ZhaoSchool of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Yinghan WangSchool of Life Science, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Xing WuSchool of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Xaofei ZengSchool of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Baoyue LinSchool of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Shengmin HuSchool of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Shenglin ZhangSchool of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Yu LiSchool of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Zhiqing ZhouSchool of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Yujie ZhouSchool of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Changzheng DuSchool of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
David G BeerDepartment of Surgery, University of Michigan Medical School, Ann Arbor, MI, USA.
Shengbin BaiDepartment of Histology and Embryology, Basic Medical College, Xinjiang Medical University, Urumqi, China.
Guoan ChenSchool of Medicine, Southern University of Science and Technology, Shenzhen, Guangdong, China.
Southern University of Science and Technology · CNUniversity of Michigan–Ann Arbor · USXinjiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Studies demonstrate that long non-coding RNAs (lncRNAs) play vital roles in cancer progression. However, the expression pattern and molecular mechanisms of lncRNA

Indexed as

AdenocarcinomaLung NeoplasmsRNA, Long NoncodingAMP-Activated Protein KinasesAutophagyCell MovementCell ProliferationHumansLungNeoplasm ProteinsProto-Oncogene Proteins c-metRNA, AntisenseAMP-Activated Protein KinasesFAM83A protein, humanMET protein, humanNeoplasm ProteinsProto-Oncogene Proteins c-metRNA, AntisenseRNA, Long NoncodingautophagyFAM83A-AS1lncRNALung adenocarcinomaMET

Identifiers

PMID35635086
PMCPMC9275865
OpenAlexW4281783908

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.